Literature DB >> 25637563

Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.

Angelo Auricchio1, Edward J Schloss2, Takashi Kurita3, Albert Meijer4, Bart Gerritse5, Steven Zweibel6, Faisal M AlSmadi7, Charles T Leng8, Laurence D Sterns9.   

Abstract

BACKGROUND: The benefits of implantable cardioverter-defibrillators (ICDs) have been well demonstrated in many clinical trials, and ICD shocks for ventricular tachyarrhythmias save lives. However, inappropriate and unnecessary shock delivery remains a significant clinical issue with considerable consequences for patients and the healthcare system.
OBJECTIVE: The purpose of the PainFree SmartShock Technology (SST) study was to investigate new-generation ICDs to reduce inappropriate and unnecessary shocks through novel discrimination algorithms with modern programming strategies.
METHODS: This prospective, multicenter clinical trial enrolled 2790 patients with approved indication for ICD implantation (79% male, mean age 65 years; 69% primary prevention indication, 27% single-chamber ICD, 33% replacement or upgrade). Patients were followed for a minimum of 12 months, and mean follow-up was 22 months. The primary end-point of the study was the percentage of patients remaining free of inappropriate shocks at 1 year postimplant, analyzed separately for dual/triple-chamber ICDs (N = 2019) and single-chamber ICDs (N = 751).
RESULTS: The inappropriate shock rate at 1 year was 1.5% for patients with dual/triple-chamber ICDs and 2.5% for patients with single-chamber devices. Two years postimplant, the inappropriate shock rate was 2.8% for patients with dual-/triple chamber ICDs and 3.7% for those with single-chamber ICDs. The most common cause of an inappropriate shock in both groups was atrial fibrillation or flutter.
CONCLUSION: In a large patient cohort receiving ICDs for primary or secondary prevention, the adoption of novel enhanced detection algorithms in conjunction with routine implementation of modern programming strategies led to a very low inappropriate shock rate.
Copyright © 2015 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Cardiac resynchronization therapy; Heart failure; Implantable cardioverter-defibrillator; Inappropriate shock

Mesh:

Year:  2015        PMID: 25637563     DOI: 10.1016/j.hrthm.2015.01.017

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  28 in total

1.  Reduction of inappropriate implantable cardioverter-defibrillator therapies using enhanced supraventricular tachycardia discriminators: the ReduceIT study.

Authors:  Johann Christoph Geller; Armin Wöhrle; Mathias Busch; Albrecht Elsässer; Thomas Kleemann; Frank Birkenhauer; Peter Bramlage; Christian Veltmann
Journal:  J Interv Card Electrophysiol       Date:  2020-07-14       Impact factor: 1.900

2.  [Inappropriate ICD therapies: All problems solved with MADIT-RIT?].

Authors:  Christof Kolb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-04-21

3.  Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices.

Authors:  Sem Briongos-Figuero; Ana Sánchez; M Luisa Pérez; José B Martínez-Ferrer; Enrique García; Xavier Viñolas; Ángel Arenal; Javier Alzueta; Nuria Basterra; Aníbal Rodríguez; Ignacio Lozano; Roberto Muñoz-Aguilera
Journal:  J Interv Card Electrophysiol       Date:  2018-12-06       Impact factor: 1.900

Review 4.  Sensing and detection in Medtronic implantable cardioverter defibrillators.

Authors:  Mark L Brown; Charles D Swerdlow
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-09-08

Review 5.  Cardiac Resynchronization in Patients with Atrial Fibrillation.

Authors:  S Serge Barold; Bengt Herweg
Journal:  J Atr Fibrillation       Date:  2015-12-31

6.  Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.

Authors:  Babak Nazer; Zack Dale; Gianmarco Carrassa; Nosheen Reza; Tuna Ustunkaya; Nikolaos Papoutsidakis; Andrew Gray; Stacey J Howell; Miriam R Elman; Paolo Pieragnoli; Giuseppe Ricciardi; Daniel Jacoby; David S Frankel; Anjali Owens; Iacopo Olivotto; Stephen B Heitner
Journal:  Heart Rhythm       Date:  2020-02-18       Impact factor: 6.343

7.  Antitachycardia pacing: A worthy cause?

Authors:  Gordon Ho; Ulrika Birgersdotter-Green
Journal:  J Cardiovasc Electrophysiol       Date:  2020-07-30       Impact factor: 2.942

8.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Authors:  Bruce L Wilkoff; Laurent Fauchier; Martin K Stiles; Carlos A Morillo; Sana M Al-Khatib; Jesœs Almendral; Luis Aguinaga; Ronald D Berger; Alejandro Cuesta; James P Daubert; Sergio Dubner; Kenneth A Ellenbogen; N A Mark Estes; Guilherme Fenelon; Fermin C Garcia; Maurizio Gasparini; David E Haines; Jeff S Healey; Jodie L Hurtwitz; Roberto Keegan; Christof Kolb; Karl-Heinz Kuck; Germanas Marinskis; Martino Martinelli; Mark McGuire; Luis G Molina; Ken Okumura; Alessandro Proclemer; Andrea M Russo; Jagmeet P Singh; Charles D Swerdlow; Wee Siong Teo; William Uribe; Sami Viskin; Chun-Chieh Wang; Shu Zhang
Journal:  J Arrhythm       Date:  2016-02-01

9.  Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry.

Authors:  Hillel Steiner; Michael Geist; Ilan Goldenberg; Mahmoud Suleiman; Michael Glikson; Alexander Tenenbaum; Moshe Swissa; Enrique Z Fisman; Gregory Golovchiner; Boris Strasberg; Alon Barsheshet
Journal:  Cardiovasc Diabetol       Date:  2016-12-01       Impact factor: 9.951

10.  A case of inappropriate implantable cardioverter defibrillator therapy induced by T-wave oversensing due to hyperkalemia.

Authors:  Kosuke Aoki; Katsunori Okajima; Kunihiko Kiuchi; Kiminobu Yokoi; Jin Teranishi; Akira Shimane
Journal:  J Arrhythm       Date:  2015-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.